Ratings by Laidlaw (Francois Brisebois)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/18/2020 BioSig Technologies BSGM New Coverage Buy
(N/A)
2.73
(6.10)
123.44% Details
9/24/2019 Avadel Pharmaceuticals AVDL Maintain Buy
(N/A)
 
 
  Details
9/10/2019 Tiziana Life Sciences TLSA Maintain Buy
(N/A)
 
 
  Details
9/4/2019 Aridis Pharmaceuticals ARDS Maintain Buy
(N/A)
 
 
  Details
9/4/2019 Emergent BioSolutions EBS Maintain Buy
(N/A)
 
 
  Details
8/22/2019 Clearside Biomedical CLSD Maintain Hold
(N/A)
 
 
  Details
8/13/2019 Clearside Biomedical CLSD Downgrade Hold
(Buy)
1.30
(0.41)
-68.46% Details
8/12/2019 Avadel Pharmaceuticals AVDL Upgrade Buy
(Hold)
1.95
(21.64)
1009.74% Details
7/29/2019 NovaBay Pharmaceuticals NBY Maintain Hold
(N/A)
 
 
  Details
7/22/2019 Galmed Pharmaceuticals GLMD New Coverage Buy
(N/A)
6.41
(0.55)
-91.42% Details
7/8/2019 Soleno Therapeutics Inc. SLNO New Coverage Buy
(N/A)
2.67
(1.73)
-35.21% Details
6/14/2019 Taiwan Liposome Co Ltd. TLC Maintain Buy
(N/A)
 
 
  Details
5/9/2019 Flexion Therapeutics FLXN Maintain Buy
(N/A)
 
 
  Details
5/2/2019 Strongbridge Biopharma SBBP Maintain Buy
(N/A)
 
 
  Details
5/1/2019 Alimera Sciences ALIM Maintain Buy
(N/A)
 
 
  Details
4/11/2019 Flexion Therapeutics FLXN Maintain Buy
(N/A)
 
 
  Details
3/18/2019 Avadel Pharmaceuticals AVDL Maintain Hold
(N/A)
 
 
  Details
3/13/2019 NovaBay Pharmaceuticals NBY Downgrade Hold
(Buy)
1.50
(1.95)
30% Details
3/11/2019 Strongbridge Biopharma SBBP Maintain Buy
(N/A)
 
 
  Details
2/20/2019 BioSig Technologies BSGM Maintain Buy
(N/A)
 
 
  Details
1/14/2019 Intercept Pharmaceuticals ICPT Upgrade Buy
(Hold)
109.73
(19.00)
-82.68% Details
12/18/2018 Strongbridge Biopharma SBBP New Coverage Buy
(N/A)
4.37
(2.00)
-54.23% Details
12/17/2018 Tiziana Life Sciences TLSA New Coverage Buy
(N/A)
8.85
(1.07)
-87.91% Details
11/6/2018 Avadel Pharmaceuticals AVDL Downgrade Hold
(Buy)
4.02
(1.95)
-51.49% Details
11/6/2018 Clearside Biomedical CLSD Maintain Buy
(N/A)
 
 
  Details
9/10/2018 Aridis Pharmaceuticals ARDS New Coverage Buy
(N/A)
13.30
(0.00)
-100% Details